Myasthenia gravis is a chronic autoimmune disorder that inhibits communication between nerve cells and muscles, causing muscle weakness. It has no cure, but several treatment options can help improve ...

Dr Katherine Ruzhansky reviews therapeutic advances that emphasize careful patient selection and individualized combination ...

Jonathan Strober, MD, discusses the challenges of diagnosing pediatric myasthenia gravis, especially in seronegative cases, and the importance of antibody testing.

The ongoing EPIC clinical trial is the first randomized head-to-head comparison of two neonatal Fc receptor (FcRn)-targeting treatments for generalized myasthenia gravis (gMG) in adults.

Experts discuss personalized myasthenia gravis treatment, emphasizing patient education and engagement for optimal care and advocacy in managing this variable disease. Personalizing treatment for ...

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis is ...

What are called autoimmune diseases can affect just about every part of the body — and tens of millions of people. While most ...

The FDA announced the approval of Vyvgart for treatment of the chronic autoimmune, neuromuscular disease myasthenia gravis in adults who are positive for acetylcholine receptor antibody. The approval ...

Rising healthcare investments in regions like the U.S., Europe, and Japan, alongside enhanced diagnostic tools, support market dynamics. Despite challenges such as high treatment costs in low-income ...

Myasthenia gravis, or MG, is "a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue," says Hesterlee. It occurs "when a person’s immune system is essentially attacking ...